To determine whether primary AML samples respond to inhibition of USP15, we treated 3 patient-derived xenograft (PDX) AML samples with USP15-Inh (10 μM) and evaluated their colony-forming ability in vitro. Here, USP15 is linked to acute myeloid leukemia.